视网膜静脉阻塞诊疗规范——2019年欧洲视网膜专家协会指南解读  

Consensus interpretation on the specification of diagnosis and treatment of retinal vein occlusion by European Society of Retina Specialists in 2019

作　　者：邵毅[1] 张雨晴 周琼[1] SHAO Yi;ZHANG Yuqing;ZHOU Qiong(Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China)

机构地区：[1]南昌大学第一附属医院眼科,江西省南昌市330006

出　　处：《眼科新进展》2020年第6期501-504,共4页Recent Advances in Ophthalmology

基　　金：国家自然科学基金资助(编号81660158);江西省自然科学基金重大项目(编号2016ACB21017);江西省青年科学基金(编号20151BAB215016,20161BAB215198);江西省重点研发项目(编号20151BBG70223,20181BBG70004);江西省杰出青年人才计划(S2019RCQNB0259);江西省学位与研究生教育教学改革研究项目(编号JXYJG-2018-013)。

摘　　要：视网膜静脉阻塞是一种临床上常见的视网膜血管疾病,表现为视网膜急性和过度渗漏并伴有增厚,是视网膜出血和水肿的诊断标志。欧洲视网膜专家协会基于最新的文献和专家意见整合出了视网膜疾病最新治疗指南。本文将对其进行详细解读,并推荐应用。Retinal vein occlusion(RVO)is a common retinal vascular disease.It is characterized by acute and excessive retinal leakage accompanied by thickening,which is the diagnostic marker of retinal hemorrhage and edema.The European Society of Retina Specialists(EURETINA)has developed the latest guidelines for the treatment of retinal diseases based on the latest literature and expert advices,and we explicate it in this article for wide application in China.

关 键 词：视网膜静脉阻塞 光学相干断层扫描 抗血管内皮生长因子治疗 激素 激光治疗 

分 类 号：R774.1[医药卫生—眼科]